May. 15 at 2:52 AM
$TWST from a recent SA article;
Twist Bioscience (NASDAQ:TWST) reported solid results in the second quarter of FY2025, but the management team appeared downbeat on the earnings call. Twist has also chosen to spin out its data storage segment, with a fairly modest value attached to the business. The move appears to have been driven by a soft macro environment and Twist's desire to continue accelerating its transition to profitability. While Twist has faced weak demand for several years, tariffs and concerns around academic funding appear to have created additional uncertainty.
